Pablo Cagnoni, Rubius Therapeutics CEO
Rubius resorts to layoffs and abandons its lead programs as its survival strategy
Four years ago, Cambridge-based Rubius Therapeutics was having the time of its life. The company, which makes engineered red cells, was raking in ample cash …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
